{"title":"Research & Innovation Abstracts","authors":"Roshelle Ramkisson","doi":"10.38192/1.8.3.1","DOIUrl":"https://doi.org/10.38192/1.8.3.1","url":null,"abstract":"BAPIO Institute for Health Research","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135351394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Keynote on 'Global trends in healthcare sustainability Digital Revolution in Health Care
关于“医疗保健可持续发展的全球趋势”的主题演讲
{"title":"The Importance of an Innovation Culture in the NHS","authors":"D. Behan","doi":"10.38192/1.8.2.12","DOIUrl":"https://doi.org/10.38192/1.8.2.12","url":null,"abstract":"Keynote on 'Global trends in healthcare sustainability Digital Revolution in Health Care","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"48 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81777260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. Dodds, Joydeep Grover, A. Mahmood, Triya Chakravorty
Considering risks to healthcare covers a wide variety of topics. This cover’s an extensive area such as sustainability, including funding; planning, long-term policy development; and trends, including the emergence of publicly funded versus private healthcare or a hybrid offering. Other topics include workforce planning, involving the consideration of self-sufficiency versus importing; examination of delivery modes of hospitals versus community; and final consideration of balancing affordability with expectation and need. As part of a consideration of risk is an anticipation of what dangers may arise. This can be borne out of existing knowledge of known threats, which remain ongoing, trends and predicted risk patterns, and unexpected risks.
{"title":"Reducing Risks in Healthcare by Prioritising Workforce Well-being","authors":"S. Dodds, Joydeep Grover, A. Mahmood, Triya Chakravorty","doi":"10.38192/1.8.2.5","DOIUrl":"https://doi.org/10.38192/1.8.2.5","url":null,"abstract":"Considering risks to healthcare covers a wide variety of topics. This cover’s an extensive area such as sustainability, including funding; planning, long-term policy development; and trends, including the emergence of publicly funded versus private healthcare or a hybrid offering. Other topics include workforce planning, involving the consideration of self-sufficiency versus importing; examination of delivery modes of hospitals versus community; and final consideration of balancing affordability with expectation and need. As part of a consideration of risk is an anticipation of what dangers may arise. This can be borne out of existing knowledge of known threats, which remain ongoing, trends and predicted risk patterns, and unexpected risks.","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"123 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88098915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Beth Farrer, Helen Nesbitt, L. Osborne, Camilla Stanley, G. Nargund
The case for making healthcare more sustainable is becoming increasingly urgent. Medical professionals understand the need to reduce the cost and environmental impact of our work. We also see that being creative in how we plan treatment pathways and communicate with patients can allow us to work sustainably in terms of the resources required, and in tandem, deliver real benefits for patients. Approaches that deliver ‘prevention rather than cure’ and keep medical intervention as minimally invasive as possible are often better for patients, as well as better for the environment. These concepts are particularly pertinent in the field of reproductive and women’s health, where CREATE Fertility specialise in adopting an approach that is friendly and safe. With natural and mild IVF treatment, delivered with lower doses of drugs, CREATE is able to offer women treatment that reduces risks, side effects and the burden of IVF and supports healthier outcomes for mother and baby, while maintaining outcomes. That philosophy of putting patients first and finding a more efficient way to work is at the heart of the foundation of CREATE’s ABC IVF. In the UK, and around the world, access to fertility treatment is not fair or equal. For many women and couples, cost is a major barrier and one that can stop them building the family they want. In the UK, availability of NHStreatment is variable around the country. At the time of its launch, ABC IVF was the UK’s lowest cost IVF provider, offering a lifeline to thousands of patients who would not otherwise have been able to access treatment. In women’s healthcare, alongside education, innovation and research is key, yet in the UK it is acknowledged that historically there has been a ‘male as default’ approach that has affected research and clinical trials 1 . Professor Nargund is committed to helping to work towards the UN’s sustainable development goals three (health and wellbeing), five (gender inequality), ten (reduced inequality) and thirteen (climate action) with s push to provide affordable, accessible, effective and safe fertility treatment, delivered sustainably. The work is far from over and Professor Nargund and her team remain committed to improving the outlook for women’s healthcare.
{"title":"Mild In Vitro Fertilisation","authors":"Beth Farrer, Helen Nesbitt, L. Osborne, Camilla Stanley, G. Nargund","doi":"10.38192/1.8.2.4","DOIUrl":"https://doi.org/10.38192/1.8.2.4","url":null,"abstract":"The case for making healthcare more sustainable is becoming increasingly urgent. Medical professionals understand the need to reduce the cost and environmental impact of our work. We also see that being creative in how we plan treatment pathways and communicate with patients can allow us to work sustainably in terms of the resources required, and in tandem, deliver real benefits for patients. Approaches that deliver ‘prevention rather than cure’ and keep medical intervention as minimally invasive as possible are often better for patients, as well as better for the environment.\u0000These concepts are particularly pertinent in the field of reproductive and women’s health, where CREATE Fertility specialise in adopting an approach that is friendly and safe. With natural and mild IVF treatment, delivered with lower doses of drugs, CREATE is able to offer women treatment that reduces risks, side effects and the burden of IVF and supports healthier outcomes for mother and baby, while maintaining outcomes.\u0000That philosophy of putting patients first and finding a more efficient way to work is at the heart of the foundation of CREATE’s ABC IVF. In the UK, and around the world, access to fertility treatment is not fair or equal. For many women and couples, cost is a major barrier and one that can stop them building the family they want. In the UK, availability of NHStreatment is variable around the country. At the time of its launch, ABC IVF was the UK’s lowest cost IVF provider, offering a lifeline to thousands of patients who would not otherwise have been able to access treatment.\u0000In women’s healthcare, alongside education, innovation and research is key, yet in the UK it is acknowledged that historically there has been a ‘male as default’ approach that has affected research and clinical trials 1 . Professor Nargund is committed to helping to work towards the UN’s sustainable development goals three (health and wellbeing), five (gender inequality), ten (reduced inequality) and thirteen (climate action) with s push to provide affordable, accessible, effective and safe fertility treatment, delivered sustainably. The work is far from over and Professor Nargund and her team remain committed to improving the outlook for women’s healthcare.","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"35 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86929474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Artificial intelligence (AI) aims to mimic human cognitive functions. It is bringing a paradigm shift to healthcare, powered by the increasing availability of healthcare data and rapid progress of analytics techniques.1 AI can be applied to various types of healthcare data (structured and unstructured). Popular AI techniques include machine learning methods for structured data, such as the classical support vector machine and neural network, modern deep learning, and natural language processing for unstructured data. Major disease areas that use AI tools include cancer, neurology and cardiology.
{"title":"Introduction to Artificial Intelligence Prediction for Healthcare","authors":"Anindya Chakravorty","doi":"10.38192/1.8.2.7","DOIUrl":"https://doi.org/10.38192/1.8.2.7","url":null,"abstract":"Artificial intelligence (AI) aims to mimic human cognitive functions. It is bringing a paradigm shift to healthcare, powered by the increasing availability of healthcare data and rapid progress of analytics techniques.1 AI can be applied to various types of healthcare data (structured and unstructured). Popular AI techniques include machine learning methods for structured data, such as the classical support vector machine and neural network, modern deep learning, and natural language processing for unstructured data. Major disease areas that use AI tools include cancer, neurology and cardiology. ","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85069918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
It is estimated that this unequal world we live in, will need 80 million health workers to meet the demands of the global population by the end of the decade, double the number in 2013.1,2 The population distribution across the globe is skewed (Fig 1) with high densities in Africa, South Asia and South America which characteristically remains mismatched to their gross domestic product and net wealth, which is enjoyed by nations with the least population densities (Fig 2). Healthcare provision within geo-politically separated nation-states continues to be driven by local social, political and economic factors. Therefore, the adage of ‘no size fits all’ is applicable. No two countries have the same healthcare system, anywhere in the world, we know today. Yet the desire to achieve ‘Health for All’ should be universal.3 Implementation of the fundamental principle that health promotion and prevention must be prioritised before the resource intense diagnosis and management of maladies, is believed to be the only way to achieve any form of sustainability in healthcare provision.
{"title":"Mutually Beneficial Immigration is Key to Global Healthcare Sustainability","authors":"Ramesh Mehta, I. Chakravorty","doi":"10.38192/1.8.2.6","DOIUrl":"https://doi.org/10.38192/1.8.2.6","url":null,"abstract":"It is estimated that this unequal world we live in, will need 80 million health workers to meet the demands of the global population by the end of the decade, double the number in 2013.1,2 The population distribution across the globe is skewed (Fig 1) with high densities in Africa, South Asia and South America which characteristically remains mismatched to their gross domestic product and net wealth, which is enjoyed by nations with the least population densities (Fig 2). Healthcare provision within geo-politically separated nation-states continues to be driven by local social, political and economic factors. Therefore, the adage of ‘no size fits all’ is applicable. No two countries have the same healthcare system, anywhere in the world, we know today. Yet the desire to achieve ‘Health for All’ should be universal.3 Implementation of the fundamental principle that health promotion and prevention must be prioritised before the resource intense diagnosis and management of maladies, is believed to be the only way to achieve any form of sustainability in healthcare provision.","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87532665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Polycystic ovary syndrome (PCOS) is the commonest metabolic and endocrine disorder that affects women of reproductive age. It is characterised by irregular menstruation, hyperandrogenism and polycystic ovarian morphology. While significant progress has been made in understanding PCOS, several research questions remain. For instance, there is a need for further investigation into the aetiology of PCOS, including the role of genetic and environmental factors, to aid in earlier diagnosis and treatment. Additionally, while some therapies have been effective in managing the symptoms of PCOS, their long-term efficacy and safety remain uncertain. There is a need to better understand the long-term health consequences of PCOS, particularly regarding cardiovascular disease and cancer risk. Early diagnosis, lifestyle modifications, and appropriate medical interventions can help to reduce the risk of complications and improve the overall health outcomes of women with PCOS. Looking forward, there is a need for a multidisciplinary approach to studying PCOS, including collaborations between researchers, healthcare providers, and patient advocacy groups. This may involve developing new tools and technologies for diagnosis and treatment and exploring novel interventions and therapies. There is a growing recognition of the importance of PCOS as a significant health issue affecting millions of women worldwide, and continued research efforts will be critical for improving diagnosis, treatment, and long-term outcomes for those affected by the condition.
{"title":"Understanding Polycystic Ovary Syndrome (PCOS):","authors":"Triya Chakravorty","doi":"10.38192/1.8.2.3","DOIUrl":"https://doi.org/10.38192/1.8.2.3","url":null,"abstract":"Polycystic ovary syndrome (PCOS) is the commonest metabolic and endocrine disorder that affects women of reproductive age. It is characterised by irregular menstruation, hyperandrogenism and polycystic ovarian morphology.\u0000 \u0000While significant progress has been made in understanding PCOS, several research questions remain. For instance, there is a need for further investigation into the aetiology of PCOS, including the role of genetic and environmental factors, to aid in earlier diagnosis and treatment. Additionally, while some therapies have been effective in managing the symptoms of PCOS, their long-term efficacy and safety remain uncertain. There is a need to better understand the long-term health consequences of PCOS, particularly regarding cardiovascular disease and cancer risk.\u0000 \u0000Early diagnosis, lifestyle modifications, and appropriate medical interventions can help to reduce the risk of complications and improve the overall health outcomes of women with PCOS. Looking forward, there is a need for a multidisciplinary approach to studying PCOS, including collaborations between researchers, healthcare providers, and patient advocacy groups. This may involve developing new tools and technologies for diagnosis and treatment and exploring novel interventions and therapies.\u0000There is a growing recognition of the importance of PCOS as a significant health issue affecting millions of women worldwide, and continued research efforts will be critical for improving diagnosis, treatment, and long-term outcomes for those affected by the condition.","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"55 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88855988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A call to action, Surgical Metacognition: Smarter Decision-making for Surgeons challenges surgeons to understand the processes that underpin decision-making and performance, and how we can use this new knowledge to improve a surgeon's performance both in and outside the operating theatre. Decision-making is a core professional activity for surgeons of all levels. It is a distinct high-level skill that is closely associated with the quality of surgical outcomes, patient satisfaction, teamwork, and a surgeon's well-being. Yet it has so far been woefully neglected in surgical training and professional development, with an assumption that these skills develop on their own and cannot be taught or improved. This is an unfortunate and costly oversight that it is time we redress. But how are good decisions and expertise made? And how can we as a profession improve our thinking to optimize our decision-making and train expertise? The answer lies not only in gaining more knowledge and experience, which although essential for good decision-making, do not address the fact that so few of us understand the process itself, let alone how to optimize and teach it. The first step, and focus of this book, is understating 'metacognition'; 'thinking about thinking, ' to improve self-awareness, critical thinking and how we make decisions. The profound developments of psychology and decision-science are now well established and have been successfully incorporated into other high-stakes professions such as senior business management, the military and aviation, to significantly improve both professional and personal outcomes. That surgery has yet to implement this knowledge is like a race car driver using a car with technology that is decades old, ignoring developments that would significantly increase performance. It is time for surgery to embrace this knowledge; to advance and modernize the profession with sharper critical thinking and teaching. With many real-world surgical examples, Surgical Metacognition: Smarter Decision-making for Surgeons reviews the psychological understanding of decisions and decision-making from recent decades of research, giving us the tools to improve how we think and teach this fundamental skill of expertise.
{"title":"Metacognition for Every Clinician","authors":"U. Shiralkar","doi":"10.38192/1.8.2.9","DOIUrl":"https://doi.org/10.38192/1.8.2.9","url":null,"abstract":"A call to action, Surgical Metacognition: Smarter Decision-making for Surgeons challenges surgeons to understand the processes that underpin decision-making and performance, and how we can use this new knowledge to improve a surgeon's performance both in and outside the operating theatre. \u0000Decision-making is a core professional activity for surgeons of all levels. It is a distinct high-level skill that is closely associated with the quality of surgical outcomes, patient satisfaction, teamwork, and a surgeon's well-being. Yet it has so far been woefully neglected in surgical training and professional development, with an assumption that these skills develop on their own and cannot be taught or improved. This is an unfortunate and costly oversight that it is time we redress. \u0000But how are good decisions and expertise made? And how can we as a profession improve our thinking to optimize our decision-making and train expertise? \u0000The answer lies not only in gaining more knowledge and experience, which although essential for good decision-making, do not address the fact that so few of us understand the process itself, let alone how to optimize and teach it. The first step, and focus of this book, is understating 'metacognition'; 'thinking about thinking, ' to improve self-awareness, critical thinking and how we make decisions. \u0000The profound developments of psychology and decision-science are now well established and have been successfully incorporated into other high-stakes professions such as senior business management, the military and aviation, to significantly improve both professional and personal outcomes. That surgery has yet to implement this knowledge is like a race car driver using a car with technology that is decades old, ignoring developments that would significantly increase performance. It is time for surgery to embrace this knowledge; to advance and modernize the profession with sharper critical thinking and teaching. \u0000With many real-world surgical examples, Surgical Metacognition: Smarter Decision-making for Surgeons reviews the psychological understanding of decisions and decision-making from recent decades of research, giving us the tools to improve how we think and teach this fundamental skill of expertise.","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78857550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Innovation is defined by the dictionaries as “a new idea, device, or method; or the act or process of introducing new ideas, devices, or methods.” However, Surgical Innovation (SI) is more difficult to define. Common narratives include why-where-how-what-who as well as novelty, degree of change, safety, ethical standards, level of impact and peer acceptance. [1, 2] We have proposed a simpler, more egalitarian and ‘inclusive’ definition: “a SI is ‘any’ new surgical idea which improves patient welfare by solving an existing problem; and which like a three-legged stool is balanced by the three legs which represent surgical-precision, surgical-wisdom and patient-safety”. [3] Frugal Surgical Innovations (FSIs) are low-cost surgical innovations which are designed for economic reasons. These are all about ‘doing more and better with less for more people’. [4] FSIs make up for their lack in sophistication or complexity in affordability, without scrimping on safety or effectiveness. The three constructs of FSIs are: affordability, adaptability and accessibility. [5] The philosophy of FSIs originates from grassroots, resource-constrained settings (RCS), where most abundant of all-natural resources — human ingenuity — is used to optimize limited resources to solve problems. [6] Clinically meaningful inclusive research can be performed ‘only’ by surgeons working in RCS; as ‘only’ they understand the difficulties and nuances of various problems and can provide simple affordable solutions for their patients. [7]
{"title":"Frugal Surgical Innovations are the Need of the Hour","authors":"D. Sharma","doi":"10.38192/1.8.2.8","DOIUrl":"https://doi.org/10.38192/1.8.2.8","url":null,"abstract":"Innovation is defined by the dictionaries as “a new idea, device, or method; or the act or process of introducing new ideas, devices, or methods.” However, Surgical Innovation (SI) is more difficult to define. Common narratives include why-where-how-what-who as well as novelty, degree of change, safety, ethical standards, level of impact and peer acceptance. [1, 2] We have proposed a simpler, more egalitarian and ‘inclusive’ definition: “a SI is ‘any’ new surgical idea which improves patient welfare by solving an existing problem; and which like a three-legged stool is balanced by the three legs which represent surgical-precision, surgical-wisdom and patient-safety”. [3] \u0000Frugal Surgical Innovations (FSIs) are low-cost surgical innovations which are designed for economic reasons. These are all about ‘doing more and better with less for more people’. [4] FSIs make up for their lack in sophistication or complexity in affordability, without scrimping on safety or effectiveness. The three constructs of FSIs are: affordability, adaptability and accessibility. [5] The philosophy of FSIs originates from grassroots, resource-constrained settings (RCS), where most abundant of all-natural resources — human ingenuity — is used to optimize limited resources to solve problems. [6] Clinically meaningful inclusive research can be performed ‘only’ by surgeons working in RCS; as ‘only’ they understand the difficulties and nuances of various problems and can provide simple affordable solutions for their patients. [7]","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"248 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89174172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background Due to the gastrointestinal side-effects of oral iron supplementation in patients with iron deficiency anaemia, which impairs tolerance - many acute medical and haematology day units provide intravenous iron replacement therapy as day cases. Hypophosphatemia is a frequent side effect following intravenous iron administration, which can persist for weeks or months, is under-recognised in clinical practice and can lead to patients presenting with typical features to the emergency departments. Aim We designed an audit to measure the incidence of symptomatic hypophosphatemia after intravenous iron therapy to develop monitoring, prevention, and treatment strategy in a secondary care hospital setting. Methods We audited a convenience sample of consecutive patients who attended an acute day-care assessment unit for intravenous (IV) iron infusion (ferric carboxymaltose). All patients had serum phosphate levels checked after IV iron infusion at different intervals, from 1- 6 weeks. The cohort was divided into two groups based on the occurrence of hypophosphataemia - early (1-3 weeks) and late (>3-6 weeks). Results We included 35 patients referred from primary care, gastroenterology, gynaecology, and acute internal medicine. 19 (55%) developed hypophosphatemia after receiving a single IV iron infusion and almost 100% after more than one dose. Hypophosphatemia in some patients lasted up to 12 weeks. Conclusion Hypophosphatemia was frequent after a single dose and almost universal after multiple doses of IV Iron, which can persist for many weeks. Clinicians prescribing ferric carboxymaltose (Ferinject®) should be aware of hypophosphataemia, which could be mild, moderate, or severe and can last for months.
{"title":"An Audit of Hypophosphatemia after Intravenous Iron Therapy","authors":"M. Shahani, P. Thiagarajah, I. Chakravorty","doi":"10.38192/1.8.1.13","DOIUrl":"https://doi.org/10.38192/1.8.1.13","url":null,"abstract":"Background\u0000Due to the gastrointestinal side-effects of oral iron supplementation in patients with iron deficiency anaemia, which impairs tolerance - many acute medical and haematology day units provide intravenous iron replacement therapy as day cases. Hypophosphatemia is a frequent side effect following intravenous iron administration, which can persist for weeks or months, is under-recognised in clinical practice and can lead to patients presenting with typical features to the emergency departments.\u0000Aim\u0000We designed an audit to measure the incidence of symptomatic hypophosphatemia after intravenous iron therapy to develop monitoring, prevention, and treatment strategy in a secondary care hospital setting.\u0000Methods\u0000We audited a convenience sample of consecutive patients who attended an acute day-care assessment unit for intravenous (IV) iron infusion (ferric carboxymaltose). All patients had serum phosphate levels checked after IV iron infusion at different intervals, from 1- 6 weeks. The cohort was divided into two groups based on the occurrence of hypophosphataemia - early (1-3 weeks) and late (>3-6 weeks).\u0000Results\u0000We included 35 patients referred from primary care, gastroenterology, gynaecology, and acute internal medicine. 19 (55%) developed hypophosphatemia after receiving a single IV iron infusion and almost 100% after more than one dose. Hypophosphatemia in some patients lasted up to 12 weeks.\u0000Conclusion\u0000Hypophosphatemia was frequent after a single dose and almost universal after multiple doses of IV Iron, which can persist for many weeks. Clinicians prescribing ferric carboxymaltose (Ferinject®) should be aware of hypophosphataemia, which could be mild, moderate, or severe and can last for months.","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"119 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74234179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：